Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients
Clinical trial NCT00935220 · COMPLETED
Trial details
- NCT number
- NCT00935220
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2010-08-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.